Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 1/7/2020
SIETES contiene 93059 citas

 1 a 14 de 14 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Elia J. Celecoxib gets partial exoneration from FDA panels. Physician's First Watch 2018:26 de abril. [Ref.ID 102574]
2. Cita con resumen
Grosser T, Ricciotti E, Fitzgerald GA. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci 2017;38:733-48. [Ref.ID 101990]
3.Tiene citas relacionadas Cita con resumen
Grosser T. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2017;376:1389-90. [Ref.ID 101526]
Felson DT. Safety of nonsteroidal antiinflammatory drugs.. N Engl J Med 2016;373:2595-6. [Ref.ID 101348]
5. Cita con resumen
Anónimo. Celecoxib safety revisited. The Medical Letter on Drug and Therapeutics Bulletin 2016;58:159. [Ref.ID 101041]
6.Tiene citas relacionadas Cita con resumen
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckeman B, Berger MF, Bao W, Lincoff AM, for the PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016;373:2519-29. [Ref.ID 101038]
7. Cita con resumen
Elmore JG, Nelson HD, Pepe MS, Longton GM, Tosteson ANA, Geller B, Onega T, Carney PA, Jackson SL, Allison KH, Weaver DL. Variability in pathologists' interpretations of individual breast biopsy slides: a population perspective. Ann Intern Med 2016;164:649-55. [Ref.ID 100080]
8. Cita con resumen
Lenzer J. Truly independent research?. BMJ 2008;337:602-6. [Ref.ID 83973]
9. Cita con resumen
Grimes D. The nomogram epidemic: resurgence of a medical relic. Ann Intern Med 2008;149:273-5. [Ref.ID 83815]
10.Tiene citas relacionadas Cita con resumen
Chan FKL, Wong VWS, Suen BY, Wu JCY, Ching JYL, Hung LCT, Hui AJ, Leung VK, Lee VWY, Lai LH, Wong GLH, Chow DKL, To KF, Leung W-K, Chiu PWY, Lee YT, Lau JYW, Chan HLY, Ng EKW, Sung JJY. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007;369:1621-6. [Ref.ID 80059]
11.Tiene citas relacionadas
Scheiman JM, Fendrick AM. Summing the risk of NSAID therapy. Lancet 2007;369:1580-1. [Ref.ID 80054]
12.Enlace a cita original Cita con resumen
Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42. [Ref.ID 79469]
13. Cita con resumen
Anónimo. New threat to Celebrex safety profile. Scrip 2006;3138:24. [Ref.ID 76308]
14. Cita con resumen
Anónimo. Celebrex CV safety in the balance with new study. Scrip 2005;3117:22. [Ref.ID 75777]
Seleccionar todas
 1 a 14 de 14